Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017 (2017), Article ID 8276939, 7 pages
https://doi.org/10.1155/2017/8276939
Research Article

Upregulation of FBXW7 Suppresses Renal Cancer Metastasis and Epithelial Mesenchymal Transition

1Department of Urology, Guangdong Second Provincial General Hospital, The Third Clinical Medical College of Southern Medical University, Guangzhou, Guangdong, China
2Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China

Correspondence should be addressed to Guosheng Yang

Received 12 March 2017; Accepted 2 August 2017; Published 30 September 2017

Academic Editor: Paola Gazzaniga

Copyright © 2017 Yangke Cai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Jonasch, J. Gao, and W. K. Rathmell, “Renal cell carcinoma,” British Medical Journal, vol. 349, article g4797, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Gupta, J. D. Miller, J. Z. Li, M. W. Russell, and C. Charbonneau, “Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review,” Cancer Treatment Reviews, vol. 34, no. 3, pp. 193–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. R. J. Motzer and P. Russo, “Systemic therapy for renal cell carcinoma,” The Journal of Urology, vol. 163, no. 2, pp. 408–417, 2000. View at Publisher · View at Google Scholar
  4. R. J. Motzer, T. E. Hutson, P. Tomczak et al., “Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma,” Journal of Clinical Oncology, vol. 27, no. 22, pp. 3584–3590, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. Motzer and A. M. Molina, “Targeting renal cell carcinoma,” Journal of Clinical Oncology, vol. 27, no. 20, pp. 3274–3276, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. R. Skaar, J. K. Pagan, and M. Pagano, “SnapShot: F box proteins I,” Cell, vol. 137, no. 6, p. 1160.e1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Cardozo and M. Pagano, “The SCF ubiquitin ligase: insights into a molecular machine,” Nature Reviews Molecular Cell Biology, vol. 5, no. 9, pp. 739–751, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Cheng and G. Li, “Role of the ubiquitin ligase Fbw7 in cancer progression,” Cancer Metastasis Reviews, vol. 31, no. 1-2, pp. 75–87, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Ljungberg, K. Bensalah, S. Canfield et al., “EAU guidelines on renal cell carcinoma: 2014 update,” European Urology, vol. 67, no. 5, pp. 913–924, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. J. P. Thiery, H. Acloque, R. Y. Huang, and M. A. Nieto, “Epithelial-mesenchymal transitions in development and disease,” Cell, vol. 139, no. 5, pp. 871–890, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. E. Fata, A. T. Ho, K. J. Leco, R. A. Moorehead, and R. Khokha, “Cellular turnover and extracellular matrix remodeling in female reproductive tissues: functions of metalloproteinases and their inhibitors,” Cellular and Molecular Life Sciences, vol. 57, no. 1, pp. 77–95, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Fu, Y. Lin, Z. Yang et al., “FBXW7 overexpression suppresses renal cancer cell proliferation and induces apoptosis,” Medical Oncology, vol. 32, no. 8, p. 215, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Wang, Y. Liu, J. Lu et al., “Rapamycin inhibits FBXW7 loss-induced epithelial-mesenchymal transition and cancer stem cell-like characteristics in colorectal cancer cells,” Biochemical and Biophysical Research Communications, vol. 434, no. 2, pp. 352–356, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Yumimoto and K. I. Nakayama, “Fbxw7 suppresses cancer metastasis by inhibiting niche formation,” Oncoimmunology, vol. 4, no. 8, article e1022308, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. E. S. Radisky and D. C. Radisky, “Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer,” Journal of Mammary Gland Biology and Neoplasia, vol. 15, no. 2, pp. 201–212, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Yang, X. Lu, Z. Liu et al., “FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells,” Oncotarget, vol. 6, no. 8, pp. 6310–6325, 2015. View at Publisher · View at Google Scholar
  17. H. Li, Z. Wang, W. Zhang, K. Qian, W. Xu, and S. Zhang, “Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer,” Cancer Letters, vol. 370, no. 1, pp. 39–55, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. R. J. Davis, M. Welcker, and B. E. Clurman, “Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities,” Cancer Cell, vol. 26, no. 4, pp. 455–464, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Kudo-Saito, H. Shirako, T. Takeuchi et al., “Cancer metastasis is accelerated through immunosuppression during snail-induced EMT of cancer cells,” Cancer Cell, vol. 15, no. 3, pp. 195–206, 2009. View at Publisher · View at Google Scholar · View at Scopus